Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 12601 | Journal of Steroid Biochemistry and Molecular Biology | 6 | Q2 | Elsevier | 68.0% 79/247 Endocrinology, Diabetes and Metabolism | 3006 | 501 |
| 12602 | Journal of Trace Elements in Medicine and Biology | 6.3 | Q2 | Elsevier | 68.0% 26/81 Inorganic Chemistry | 5139 | 816 |
| 12603 | Journal of Medicinal and Chemical Sciences | 2.6 | Q2 | Sami Publishing Company | 68.0% 214/668 General Medicine | 1520 | 593 |
| 12604 | Biomolecules and Therapeutics | 6.2 | Q2 | Korean Society of Applied Pharmacology | 68.0% 102/321 Pharmacology | 1799 | 290 |
| 12605 | Journal of Pharmacology and Experimental Therapeutics | 6.3 | Q2 | Elsevier | 68.0% 101/321 Pharmacology | 3450 | 552 |
| 12606 | Chemical Biology and Drug Design | 5.6 | Q2 | John Wiley & Sons | 67.0% 70/212 Organic Chemistry | 4585 | 821 |
| 12607 | RSC Medicinal Chemistry | 5.6 | Q2 | Royal Society of Chemistry | 67.0% 68/212 Organic Chemistry | 4591 | 814 |
| 12608 | Journal of Biochemical and Molecular Toxicology | 6 | Q2 | John Wiley & Sons | 65.0% 46/131 Toxicology | 7393 | 1222 |
| 12609 | Anti-Cancer Agents in Medicinal Chemistry | 5.8 | Q2 | Bentham Science Publishers | 65.0% 110/321 Pharmacology | 4398 | 753 |
| 12610 | Biochimica et Biophysica Acta - Molecular Basis of Disease | 6.8 | Q2 | Elsevier | 64.0% 63/177 Molecular Medicine | 7464 | 1090 |
| 12611 | Bioorganic and Medicinal Chemistry Letters | 5.1 | Q2 | Elsevier | 63.0% 68/185 Pharmaceutical Science | 7634 | 1487 |
| 12612 | ChemBioChem | 5.2 | Q2 | John Wiley & Sons | 62.0% 79/212 Organic Chemistry | 8871 | 1710 |
| 12613 | Open Medicinal Chemistry Journal | 5 | Q2 | Bentham Science Publishers | 62.0% 70/185 Pharmaceutical Science | 105 | 21 |
| 12614 | International Journal of Peptide Research and Therapeutics | 5.5 | Q2 | Springer Nature | 62.0% 61/160 Analytical Chemistry | 3158 | 574 |
| 12615 | Molecular Pharmacology | 5.5 | Q2 | Elsevier | 62.0% 121/321 Pharmacology | 1495 | 271 |
| 12616 | Biointerface Research in Applied Chemistry | 6.4 | Q2 | AMG Transcend Association | 62.0% 118/314 Biotechnology | 12044 | 1873 |
| 12617 | Blood Cells, Molecules, and Diseases | 4.4 | Q2 | Elsevier | 61.0% 55/142 Hematology | 723 | 163 |
| 12618 | Journal of Asian Natural Products Research | 3.1 | Q2 | Taylor & Francis | 61.0% 44/112 Complementary and Alternative Medicine | 1541 | 497 |
| 12619 | Current Molecular Pharmacology | 5.5 | Q2 | KeAi Communications Co. | 61.0% 124/321 Pharmacology | 1715 | 312 |
| 12620 | Biotechnology Journal | 6.1 | Q2 | John Wiley & Sons | 59.0% 52/128 Applied Microbiology and Biotechnology | 4571 | 750 |
| 12621 | Nature Mental Health | 4.1 | Q2 | Springer Nature | 59.0% 237/580 Psychiatry and Mental Health | 828 | 203 |
| 12622 | Advances in Biological Regulation | 5.3 | Q2 | Elsevier | 58.0% 146/348 Genetics | 626 | 118 |
| 12623 | Turkish Journal of Pharmaceutical Sciences | 4.2 | Q2 | Turkish Pharmacists Association | 56.0% 81/185 Pharmaceutical Science | 1244 | 299 |
| 12624 | Journal of Gene Medicine | 5 | Q2 | John Wiley & Sons | 56.0% 44/100 Genetics (clinical) | 2033 | 407 |
| 12625 | Pharmacogenetics and Genomics | 2.6 | Q2 | Wolters Kluwer Health | 55.0% 35/77 General Pharmacology, Toxicology and Pharmaceutics | 319 | 124 |
| 12626 | Future Medicinal Chemistry | 4.8 | Q2 | Taylor & Francis | 54.0% 146/321 Pharmacology | 2674 | 552 |
| 12627 | Chemistry and Biodiversity | 3.5 | Q2 | John Wiley & Sons | 51.0% 198/404 General Chemistry | 8285 | 2355 |
| 12628 | Nanomedicine Research Journal | 3.2 | Q2 | Tehran University of Medical Sciences | 50.0% 85/171 Internal Medicine | 444 | 138 |
| 12629 | Future Cardiology | 3.1 | Q2 | Taylor & Francis | 50.0% 197/397 Cardiology and Cardiovascular Medicine | 1215 | 393 |
| 12630 | OMICS A Journal of Integrative Biology | 4.4 | Q2 | Mary Ann Liebert | 50.0% 156/314 Biotechnology | 1050 | 237 |